Immune cell engagers in solid tumors: promises and challenges of the next generation immunotherapy

In the landscape of cancer immunotherapy, immune cell engagers (ICEs) are rapidly emerging as a feasible and easy-to-deliver alternative to adoptive cell therapy for the antitumor redirection of immune effector cells. Even if in hematological malignancies this class of new therapeutics already hit t...

Descripción completa

Detalles Bibliográficos
Autores principales: Fucà, G., Spagnoletti, A., Ambrosini, M., de Braud, F., Di Nicola, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841318/
https://www.ncbi.nlm.nih.gov/pubmed/33508733
http://dx.doi.org/10.1016/j.esmoop.2020.100046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841318/
https://www.ncbi.nlm.nih.gov/pubmed/33508733
http://dx.doi.org/10.1016/j.esmoop.2020.100046

Ejemplares similares